Pharmacokinetics/Pharmacodynamics (PK/PD) Characteristics of Tolvaptan Tablet in Korean Healthy Male
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
To investigate the safety, tolerance, pharmacokinetics and pharmacodynamics of tolvaptan 15,
30 and 60 mg after single oral administration in healthy Korean male subjects.